After 24 weeks, heart rate tended to decline toward baseline levels
The April 2026 TGA alert regarding unapproved GLP-1 receptor agonists (including Retatrutide) reinforced the distinction between therapeutic use, which remains unapproved, and research-grade supply for laboratory purposes, which is legally distinct under Australian law
The reduced glycemic load of meals caused by GLP-1 is very similar to that seen when replacing a meal with a high glycemic index (GI) with that of a low GI [21] (See Fig
It is also when the psychological and behavioral changes solidify into something that looks and feels like a new relationship with food and your body
Today, the media hails them as a miracle weight loss drug
For patients in Connecticut who want to lose weight while protecting strength, energy, and lean muscle, Dr